Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:ATC_code
|
| gptkbp:hasSubgroup |
J05A - Direct acting antivirals
|
| gptkbp:includes |
J05AH - Protease inhibitors
J05AP - Integrase inhibitors J05AR - Antivirals for treatment of HCV infections J05AX - Other antivirals J05AB - Nucleosides and nucleotides excluding reverse transcriptase inhibitors J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors J05AG - Non-nucleoside reverse transcriptase inhibitors |
| gptkbp:partOf |
gptkb:Anatomical_Therapeutic_Chemical_Classification_System
|
| gptkbp:represents |
Antivirals for systemic use
|
| gptkbp:usedFor |
Treatment of viral infections
|
| gptkbp:bfsParent |
gptkb:ATC_code_J05AR
gptkb:J05AE |
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
ATC code J05
|